Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for May, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Spotlight on Market and Fed Exit Plan
- This Week's Top Value Stocks
- Anatomy of Success: National Retail Properties
- RTI: Buy or Sell: Bank of America (BAC)
- The Best ETF to Play Japan's Surge
- Roundtable Top Picks of the Week
- AWS 5/15: Econ Data - U.S. & Euro - to Play a Role
- Top-Rated Zacks Rank Sectors
- Double-Down on These Gaming Stocks
- Railroad Industry Stock Outlook - May 2013
- PFP 5/15: Why Hit New Highs on Tuesday?
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/14/2013
| Company Name | Symbol | %Change |
|---|---|---|
| INTEROIL COR | IOC | 9.57% |
| INFORMATION | III | 9.47% |
| A M R CP | AAMRQ | 6.83% |
| SCIENTIFIC L | SCIL | 5.26% |
| PACER INTL I | PACR | 5.23% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
DENTSPLY International’s ( XRAY - Analyst Report ) is set to report its first-quarter 2013 results before the opening bell on Thursday, May 9. Let us see how things are shaping up prior to the announcement.
In the last quarter, the leading dental products maker posted a 1.82% positive earnings surprise on the back of strong sales in emerging markets.
Factors to Consider this Quarter
Last quarter, DENTSPLY recorded solid profit, which surged three fold year over year. Moreover, the company has also reduced its debt level and is now well positioned to invest in accretive acquisitions and/or share repurchase programs and dividends.
The company’s overall growth strategy rests on product innovation and acquisitions. DENTSPLY’s acquisition of Astra Tech, which the company has acquired from AstraZeneca PLC ( AZN - Analyst Report ) has reinforced its foothold in the global dental market. We wait to see the impact of the changes in top management, which took place recently due to integration and realignment of global operations. However, we believe that the current condition of the world economy only offers modest growth prospects for XRAY.
Earnings Whispers?
Our proven model does not conclusively show that DENTSPLY is likely to beat earnings estimate this quarter. This is because a stock needs to have both a positive Earnings ESP (Read: Zacks Earnings ESP: A Better Method) and a Zacks Rank of #1, 2 or 3 for this to happen. This is not the case here, as you will see below.
Positive Zacks Earnings ESP: The Most Accurate Estimate stands at 57 cents, while the Zacks Consensus Estimate is pegged at 56 cents. This comes to a difference of +1.79%.
Zacks Rank #4 (Sell): XRAY’s Zacks Rank #4 (Sell) lowers the predictive power of ESP.
The Zacks Rank #4 together with +1.79% earnings ESP makes surprise prediction difficult.
Other Stocks to Consider
Here are some other companies from the medical sector you may want to consider as our model shows they have the right ingredients to post an earnings beat this quarter:
Walgreen Co. ( WAG - Analyst Report ) , Earnings ESP of +1.11% and a Zacks Rank #3 (Hold)
Sirona Dental Systems Inc. ( SIRO - Snapshot Report ) , Earnings ESP of +1.39% and a Zacks Rank #3 (Hold)
Read the full reports :
Analyst Report on XRAY
Analyst Report on AZN
Analyst Report on WAG
Snapshot Report on SIRO